Clinical trial

Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

NCT05591027

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Centella asiatica product Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-12-01

PhasePHASE1

Conditions

Mild Cognitive Impairmentunresolved

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

Centella asiatica productDRUG

PlaceboDRUG

Sponsors & collaborators

Oregon Health and Science Universitylead sponsor

Alzheimer's Associationcollaborator

Mapped research locations

PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05591027 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.